1. Home
  2. TRDA vs LYTS Comparison

TRDA vs LYTS Comparison

Compare TRDA & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • LYTS
  • Stock Information
  • Founded
  • TRDA 2016
  • LYTS 1976
  • Country
  • TRDA United States
  • LYTS United States
  • Employees
  • TRDA N/A
  • LYTS N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • TRDA Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • TRDA Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • TRDA 336.6M
  • LYTS 518.5M
  • IPO Year
  • TRDA 2021
  • LYTS N/A
  • Fundamental
  • Price
  • TRDA $8.38
  • LYTS $15.92
  • Analyst Decision
  • TRDA Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • TRDA 3
  • LYTS 2
  • Target Price
  • TRDA $25.67
  • LYTS $26.00
  • AVG Volume (30 Days)
  • TRDA 139.5K
  • LYTS 158.8K
  • Earning Date
  • TRDA 05-08-2025
  • LYTS 04-24-2025
  • Dividend Yield
  • TRDA N/A
  • LYTS 1.26%
  • EPS Growth
  • TRDA N/A
  • LYTS N/A
  • EPS
  • TRDA 0.61
  • LYTS 0.72
  • Revenue
  • TRDA $172,220,000.00
  • LYTS $547,316,000.00
  • Revenue This Year
  • TRDA N/A
  • LYTS $20.24
  • Revenue Next Year
  • TRDA N/A
  • LYTS $7.64
  • P/E Ratio
  • TRDA $14.69
  • LYTS $22.11
  • Revenue Growth
  • TRDA 5.74
  • LYTS 17.89
  • 52 Week Low
  • TRDA $7.10
  • LYTS $13.63
  • 52 Week High
  • TRDA $21.79
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 43.04
  • LYTS 50.15
  • Support Level
  • TRDA $7.71
  • LYTS $15.32
  • Resistance Level
  • TRDA $9.46
  • LYTS $16.25
  • Average True Range (ATR)
  • TRDA 0.60
  • LYTS 0.67
  • MACD
  • TRDA 0.05
  • LYTS 0.17
  • Stochastic Oscillator
  • TRDA 38.29
  • LYTS 80.22

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.

Share on Social Networks: